VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

9529	Companies
187479	Keywords
119514	Articles
100217	Press releases

Home
Companies
VALNEVA

BRIEF

published on 12/10/2025 at 17:50, 5 days 1 hour ago

Valneva obtains positive results in Phase 2 for the chikungunya vaccine in children

Valneva Safety Vaccine Phase 2 Chikungunya
BRIEF

published on 12/10/2025 at 17:50, 5 days 1 hour ago

Valneva Announces Positive Phase 2 Results for Chikungunya Vaccine in Children

Valneva SE Phase 2 Study Children's Health Chikungunya Vaccine Vaccine Safety
PRESS RELEASE

published on 12/10/2025 at 17:45, 5 days 1 hour ago

Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Valneva reports positive final phase 2 antibody persistence and safety results for children with its Chikungunya vaccine IXCHIQ®. Twelve-month data supports full dose selection for Phase 3 trial

Phase 3 Trial Valneva Vaccine Chikungunya Antibody Persistence
BRIEF

published on 12/05/2025 at 18:39, 10 days ago

VALNEVA: Declaration of Shares and Voting Rights

Euronext Paris Voting Rights Ordinary Shares Valneva 2025
BRIEF

published on 12/05/2025 at 18:39, 10 days ago

Valneva Updates Share and Voting Rights as of November 2025

Stock Options Euronext Paris Voting Rights Valneva Double Voting Rights
PRESS RELEASE

published on 12/05/2025 at 18:34, 10 days ago

VALNEVA Declaration of shares and voting rights: November 30, 2025
VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form

Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF

published on 12/03/2025 at 11:03, 12 days 8 hours ago

Valneva SE: Promising Developments in Lyme Disease Vaccine

Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
PRESS RELEASE

published on 12/03/2025 at 10:58, 12 days 8 hours ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation for Valneva SE, raising target price to €6.80. VLA15 vaccine progress and market potential analyzed

Buy Recommendation Research Update Valneva SE Market Potential VLA15 Vaccine
BRIEF

published on 11/04/2025 at 07:05, 1 month 11 days ago

Valneva's Phase 1 Trial Yields Positive Results for Zika Vaccine

Phase 1 Trial Valneva Immunogenicity Zika Vaccine Adjuvant
PRESS RELEASE

published on 11/04/2025 at 07:00, 1 month 11 days ago

Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate
Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial

Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine

Accesswire

Published on 12/15/2025 at 18:15, 55 minutes ago

Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
Published on 12/15/2025 at 16:35, 2 hours 35 minutes ago

Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 4 hours 10 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 4 hours 10 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 4 hours 40 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 18:15, 55 minutes ago

Results of EQT’s mandatory simplified cash tender offer for Waga Energy’s remaining shares
Published on 12/15/2025 at 18:07, 1 hour 2 minutes ago

POS-Transaction in Own Shares
Published on 12/15/2025 at 18:00, 1 hour 10 minutes ago

LIGHTON: Adjustment of ARR target for FY 2025
Published on 12/15/2025 at 17:45, 1 hour 25 minutes ago

EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 17:38, 1 hour 31 minutes ago

Stabilus SE approves share buyback program with a volume of up to €20 million

Les Echos

Published on 12/15/2025 at 18:30, 40 minutes ago

MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 1 hour 5 minutes ago

Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 1 hour 24 minutes ago

ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:40, 1 hour 30 minutes ago

LISI joins the SBF 120 and CAC Mid 60 indices
Published on 12/15/2025 at 17:35, 1 hour 35 minutes ago

DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025

View all LES ECHOS COMFI WIRE